SARS-CoV-2 infection protects against rechallenge in rhesus macaques

Science
Abishek ChandrashekarDan H Barouch

Abstract

An understanding of protective immunity to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is critical for vaccine and public health strategies aimed at ending the global coronavirus disease 2019 (COVID-19) pandemic. A key unanswered question is whether infection with SARS-CoV-2 results in protective immunity against reexposure. We developed a rhesus macaque model of SARS-CoV-2 infection and observed that macaques had high viral loads in the upper and lower respiratory tract, humoral and cellular immune responses, and pathologic evidence of viral pneumonia. After the initial viral clearance, animals were rechallenged with SARS-CoV-2 and showed 5 log10 reductions in median viral loads in bronchoalveolar lavage and nasal mucosa compared with after the primary infection. Anamnestic immune responses after rechallenge suggested that protection was mediated by immunologic control. These data show that SARS-CoV-2 infection induced protective immunity against reexposure in nonhuman primates.

References

Oct 1, 1990·Epidemiology and Infection·K A CallowD A Tyrrell
Oct 22, 2003·Proceedings of the National Academy of Sciences of the United States of America·Boyd YountRalph S Baric
Sep 18, 2013·Proceedings of the National Academy of Sciences of the United States of America·Trevor ScobeyRalph S Baric
Jul 19, 2016·Pathogens & Immunity·Claire DeleageJacob D Estes
Jul 23, 2016·JCI Insight·Claire DeleageJacob D Estes
Jan 25, 2020·The New England Journal of Medicine·Na ZhuUNKNOWN China Novel Coronavirus Investigating and Research Team
Jan 30, 2020·The New England Journal of Medicine·Qun LiZijian Feng
Feb 1, 2020·The New England Journal of Medicine·Michelle L HolshueUNKNOWN Washington State 2019-nCoV Case Investigation Team
Apr 3, 2020·Nature·Roman WölfelClemens Wendtner

❮ Previous
Next ❯

Citations

Jun 11, 2020·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Leonard A Mermel
May 29, 2020·Journal of Travel Medicine·Lin H ChenLeo G Visser
Jun 12, 2020·Journal of Medical Virology·Enrico BentivegnaPaolo Martelletti
Jun 9, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ferric C FangAlexander L Greninger
Jul 15, 2020·The New England Journal of Medicine·Lisa A JacksonUNKNOWN mRNA-1273 Study Group
Jul 14, 2020·Nature·Ann M ArvinHerbert W Virgin
Jul 17, 2020·Clinical and Experimental Immunology·D BakerS Amor
Jun 20, 2020·Nature·Davide F RobbianiMichel C Nussenzweig
Jun 28, 2020·Journal of Virology·John P Moore, P J Klasse
Jul 1, 2020·Journal of Travel Medicine·Mary E Wilson, Lin H Chen
Jul 15, 2020·Journal of Virology·Gustaf AhlénUNKNOWN representing the OPENCORONA consortia
Sep 2, 2020·Emerging Microbes & Infections·Elisabetta RivaGiuseppe Patti
Aug 25, 2020·Cellular and Molecular Bioengineering·Jhinuk Basu MullickJanak Gaire
Sep 15, 2020·Toxicologic Pathology·Bindu M BennetRani S Sellers
Sep 18, 2020·Abdominal Radiology·Olga R BrookJonathan L Hecht
Aug 4, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Kai WangAi-Long Huang
Sep 30, 2020·The New England Journal of Medicine·Evan J AndersonUNKNOWN mRNA-1273 Study Group
Sep 24, 2020·Nature·Florian Krammer
May 22, 2020·Science·Jingyou YuDan H Barouch
Sep 9, 2020·Nature Immunology·Leo Swadling, Mala K Maini
Sep 4, 2020·MSphere·Carolin LoosGalit Alter
Sep 11, 2020·Communicable Diseases Intelligence·UNKNOWN COVID-19 National Incident Room Surveillance Team
Aug 25, 2020·Communicable Diseases Intelligence·UNKNOWN COVID-19 National Incident Room Surveillance Team
Sep 10, 2020·Experimental Hematology & Oncology·Ehtisham Ul HaqJiancheng Guo
Sep 29, 2020·Frontiers in Immunology·Inmaculada Sanclemente-AlamanUlises Gómez-Pinedo
Aug 28, 2020·Frontiers in Medicine·Santosh Dhakal, Surendra Karki
Aug 28, 2020·Communicable Diseases Intelligence·UNKNOWN COVID-19 National Incident Room Surveillance Team
Jul 30, 2020·The New England Journal of Medicine·Kizzmekia S CorbettBarney S Graham
Aug 25, 2020·Environmental & Resource Economics·Daniel RondeauFranque Grimard
Sep 19, 2020·Reviews in Medical Virology·Harapan HarapanR Tedjo Sasmono
Sep 6, 2020·Disease Models & Mechanisms·Sarah R LeistDavid R Martinez
Sep 27, 2020·Xenotransplantation·Tanja Opriessnig, Yao-Wei Huang
Jul 19, 2020·Science Immunology·Daniel M Altmann, Rosemary J Boyton
Jul 6, 2020·Journal of Medical Primatology·JoAnn L YeeJeffrey A Roberts
Sep 5, 2020·Nature Medicine·Lisa H TostanoskiDan H Barouch
Oct 6, 2020·Frontiers in Immunology·Maria TrovatoPiergiuseppe De Berardinis
Oct 8, 2020·Critical Care : the Official Journal of the Critical Care Forum·Salleh N EhaidebAbderrezak Bouchama
Aug 26, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Kelvin Kai-Wang ToKwok-Yung Yuen
Oct 9, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Chanu RheeMichael Klompas
Sep 24, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Kelvin Kai-Wang ToKwok-Yung Yuen
Oct 8, 2020·Nature Reviews. Microbiology·Ben HuZheng-Li Shi

❮ Previous
Next ❯

Methods Mentioned

BETA
bronchoalveolar lavage
ELISA

Software Mentioned

RNAscope

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.